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Abstract 
Short communication on t(X;17)(p11.2;q21.33) 
MBTD1-CXorf67 in low-grade endometrial stromal 
sarcoma. 
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Low-grade endometrial stromal sarcoma, MBTD1, 
CXorf67, fusion 
Classification 
Note 
Low-grade endometrial stromal sarcoma belongs to 
the uterine tumors of mesenchymal origin. 
According to the current World Health Organization 
classification (2013), uterine endometrial stromal 
and related tumors are categorized as benign 
endometrial stromal nodules (ESN), low-grade 
endometrial stromal sarcomas (LGESS), high-grade 
endometrial stromal sarcomas (HGESS), 
undifferentiated endometrial sarcomas (UES)and 
uterine tumors resembling ovarian sex cord tumor. 
Low- and high-grade endometrial stromal sarcomas 
are genetically heterogeneous group of tumours, 
frequently harbouring recurrent chromosomal 
translocations. The chimeric transcripts reorted so 
far are JAZF1/SUZ12, YWHAE/FAM22, 
ZCH7/BCOR, and recombination of PFH1 with 
JAZF1, EPC1, or MEAF6 (Koontz et al., 2001; 
Micci et al., 2006;Lee et al., 2012; Panagopoulos et 
al.2012; Panagopoulos et al., 2013; Oliva et al., 
2013). 
Clinics and pathology 
Disease 
Low-grade endometrial stromal sarcoma (LGESS) 
with t(X;17) translocation 
Phenotype / cell stem origin 
Unknown 
Embryonic origin 
The cellular origin of this low grade sarcoma is 
unknown, but the tumor cells presumably derive 
from the early mesenchymal endometrial progenitor 
cells. 
Etiology 
Unknown. 
Epidemiology 
The true incidence of t(X;17) LGESS is unknown. 
Two cases in females of respectively reproductive 
and postmenopausal age have been reported to date 
(Amant et al.,2003; Dewaele et al, 2014). 
Clinics 
The patients presented with abnormal uterine 
bleeding and abdominal pain. 
Pathology 
Classical cases of LGESS are composed of cells that 
morphologically resemble non-neoplastic 
proliferative-phase or hyperplastic endometrial 
stromal cells (Chiang and Oliva, 2013).  
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The tumors consist of cellular spindle cells aligned in short intersecting fascicles, without nuclear pleomorphism or atypia, and 
show rare mitotic figures (H&E; original magnification, x400). 
On cut surfaces, the tumor lesions are solid and 
white-yellowish with a glassy appearance. 
Hematoxylin and eosin stained slides show 
myometrial permeation by wormlike masses and 
frequent lymphatic infiltration.  
The tumor cells have bland nuclear features with 
monotonous oval to spindle cells concentrically 
proliferating around a rich vascular network of 
arterioles and capillaries.  
Mitotic figures are rare. By immunohistochemistry, 
the tumour components are diffusely and strongly 
positive for CD10 antigen and for oestrogen and 
progesterone receptors (Oliva et al., 2013). 
Treatment 
Surgical resection of the tumor, followed by 
hormonal treatment 
Prognosis 
The two reported patients showed a relatively 
indolent clinical course in spite of their metastatic 
disease (Amant et al.,2003; Dewaele et al, 2014). 
t(X;17)(p11;q23) G-banding. Arrows indicate chromosome breakpoints. 
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Interphase FISH on paraffin section of a low-grade ESS using SpectrumGreen-labelled (green signal) and SpectrumOrange-
labelled (red signal) RP11-379/17q21.33 and RP11-348F1/Xp11.22 BAC probes, which cover the MBTD1 and CXorf67 genes, 
respectively. Arrows indicate the presence of MBTD1-CXorf67 fusion. PROBES: BAC clone for MBTD1: RP11-379D19 covering 
the gene. BAC clone for CXorf67: RP11-348F1 covering the gene 
Cytogenetics 
Cytogenetics Morphological 
Reciprocal t(X;17)(p11.2;q21.33) translocation has 
been observed in all reported cases. 
Cytogenetics Molecular 
Metaphase FISH analysis of two LGESS cases using 
BAC RP11-379D19 DNA probe resulted in a split 
signal, which defined the 17q21.33 translocation 
breakpoint to the MBTD1 gene (data not shown).  
Using a panel of fosmid probes, a minimal shared 
breakpoint region in Xp11.22 could be mapped to 
position 51.136-51.321 Mb; this region contains 
three genes (NUDT10, CXorf67 and NUDT11). 
Whole transcriptome paired-end sequencing of two 
LGESS on Illumina HiSeq II platform identified 
CXorf67 as the partner gene on the X chromosome. 
One additional LGESS case with the MBTD1-
CXorf67 fusion was identified using interphase 
FISH with probes that map to sequences covering the 
CXorf67 and MBTD1 genomic loci (Figure 3). 
Genes involved and 
proteins 
MBTD1 
Location 
17q21.33 (position 51,177,425-51,260,163 on the 
chromosome 17 genomic sequence according to the 
UCSC database; assembly of December 2013) 
DNA / RNA 
The gene consists of 17 exons that span 79.46 kb of 
genomic DNA in the telomere-to-centromere 
orientation. The translation initiation codon and the 
stop codon are predicted to exon 1 and exon 17, 
respectively. The corresponding wild-type mRNA 
transcript is 5.3 kb (NM_017643.2). MBTD1 shows 
high level expression in normal fallopian tube in 
comparison to medium level expression in normal 
endometrium. 
Protein 
The open reading frame is predicted to encode a 628 
amino acid protein with an estimated molecular 
weight of 70 kDa. 
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The MBTD1 gene consists of 17 exons that span 79.46 kb of genomic DNA in the telomere-to-centromere orientation. 
CXorf67 
Location 
Xp11.22 (51,406,915-51,408,843 on the 
chromosome X genomic sequence according to the 
UCSC database; assembly of December 2013). 
DNA / RNA 
The gene consists of 1 exon that spans 1.92 kb of 
genomic DNA in the centromere-to-telomere 
orientation. It is entirely nested in another gene, 
namely in the intron 1-2 of the RP11-348F1.2 non-
coding gene (Yu et al., 2005). The corresponding 
wild-type mRNA transcript is 1.929 kb 
(NM_203407). CXorf67 is highly overexpressed in 
normal oocytes in comparison to low-level 
expression in other tissues, including normal 
endometrium. 
Protein 
The CXorf67 open reading frame is predicted to 
encode a 503 amino acid protein (NP_981952.1). 
Result of the chromosomal 
anomaly 
Hybrid Gene 
Description 
The t(X;17)(p11.2;q21.33) results in a MBTD1-
CXorf67 chimeric gene in which exon 16 of MBTD1 
is fused to exon 1 of CXorf67. 
Transcript 
The MBTD1-CXorf67 fusion transcript is 3142 bp 
in length (2514 bp without UTR and without Stop 
codon).  
The MBTD1-CXorf67 fusion formation is correlated 
with the CXorf67 3' domains overexpression. 
Detection 
The hybrid gene can be visualized by FISH using 
gene specific probes or by RT-PCR. 
The CXorf67 gene consists of 1 exon that spans 1.92 kb of genomic DNA in the centromere-to-telomere orientation. 
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The sequence of the MBTD1-CXorf67 junction is shown, with the structure of the MBTD1-CXorf67 cDNA depicted below (the 
dashed arrow indicates the fusion point). 
The predicted MBTD1-CXorf67 fusion protein is shown. Red boxes: the FCS and the four MBT domains of MBTD1; grey box: the 
Serine-rich domain of CXorf67. 
Fusion Protein 
Description 
The MBTD1-CXorf67 fusion transcript is predicted 
to encode a chimeric protein of 839 amino acids 
that contains the FCS-type zinc finger domain and 
the four MBT domains of MBTD1 and the Serine-
rich region of CXorf67. 
To be noted 
The aCGH data and gene expression data were 
submitted to the GEO database (Series GSE46285, 
SubSeries GSE46284: aCGH data; SubSeries 
GSE45783: gene expression profiling data). 
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